The North American Pancreatitis Study
NCT01545167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2980
Last updated 2017-09-15
Summary
This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis. No treatment is offered as part of this study. Subjects have one single visit to provide a blood sample for genetic testing and to answer a questionnaire. Subjects are not given results of genetic testing. The study is currently enrolling African American subjects and controls only.
Conditions
Interventions
- GENETIC
-
blood sampling
blood samples obtained to extract biomarkers and dna for analysis, questionnaires
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Eligibility
- Min Age
- 14 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- United States
Study Locations
More Related Trials
-
Imaging Biomarkers of Pancreatic Function and Disease
NCT05659147 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
NCT02471170 ·Status: ENROLLING_BY_INVITATION
-
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT03250078 ·Status: RECRUITING
-
Pancreas Registry and High Risk Registry
NCT02775461 ·Status: RECRUITING
-
Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Recurrent Acute Pancreatitis.
NCT06253117 ·Status: RECRUITING ·Phase: PHASE2
-
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
NCT00100321 ·Status: TERMINATED
-
Studying Biomarkers in Patients With Pancreatic Cancer
NCT00900003 ·Status: COMPLETED
-
Blood Markers of Early Pancreas Cancer
NCT03568630 ·Status: RECRUITING
-
Pancreatic Cancer Screening for At-risk Individuals
NCT05006131 ·Status: RECRUITING
-
Acute Pancreatitis Patient Registry To Examine Novel Therapies In Clinical Experiences (APPRENTICE)
NCT03075618 ·Status: COMPLETED
-
Pilot Study of Pancreatic Cancer Screening
NCT05058846 ·Status: RECRUITING
-
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
NCT02244164 ·Status: TERMINATED ·Phase: NA
-
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
NCT03165188 ·Status: TERMINATED
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
Intermittent Fasting for Pancreatitis
NCT04760847 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants
NCT00898482 ·Status: COMPLETED
-
Cancer of the Pancreas Screening Study (CAPS 3)
NCT00438906 ·Status: COMPLETED
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
NCT00830557 ·Status: RECRUITING
-
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502 ·Status: RECRUITING
-
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT01102556 ·Status: RECRUITING
-
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
NCT02743364 ·Status: COMPLETED ·Phase: PHASE2
-
Expression of Inflammatory Proteins in Pancreatic Cancer
NCT00551057 ·Status: UNKNOWN
-
Biomarker Study of Pancreatic Neuroendocrine Tumours
NCT03741517 ·Status: UNKNOWN
-
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01416662 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis
NCT01146561 ·Status: TERMINATED ·Phase: PHASE2